STATE OF WISCONSIN
CONTROLLED SUBSTANCES BOARD
---------------------------------------------------------------------------------------------------------------------
IN THE MATTER OF RULE-MAKING : AFFIRMATIVE ACTION
PROCEEDINGS BEFORE THE : ORDER OF THE
CONTROLLED SUBSTANCES BOARD : CONTROLLED SUBSTANCES BOARD
---------------------------------------------------------------------------------------------------------------------
FINDINGS
1. On November 22, 2022, the Department of Justice, Drug Enforcement Administration published its final rule in the Federal Register adding Mesocarb to schedule I of the federal Controlled Substances Act. The scheduling action is effective December 22, 2022.
2. The Controlled Substances Board did not receive an objection to similarly listing Mesocarb as a schedule I under ch. 961, Stats. within 30 days of the date of publication in the federal register of the final order listing Mesocarb as a schedule I controlled substance. 3. The Controlled Substances Board will promulgate a final rule, without making the determinations or findings required by ss. 961.11(1), (1m), (1r) and (2) or s. 961.19 and omitting the notice of proposed rulemaking, listing Mesocarb as a schedule I controlled substance. ORDER
Pursuant to s. 961.11(4), Stats., the Controlled Substances Board by affirmative action similarly treats Mesocarb under chapter 961, Stats. by creating the following: CSB 2.99 Addition of Mesocarb to schedule I. Section 961.14 (7) (s), Stats., is created to read:
961.14 (7) (s) N-phenyl- N’ –(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate, commonly known as Mesocarb.
This order shall become effective upon publication in the Administrative Register. The order expires upon promulgation of a final rule.
